FDA Drug Recalls

Recalls / Class II

Class IID-1582-2019

Product

Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10 Unit Dose Blisters), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217, NDC Carton: 62584-693-21; NDC Unit Dose: 62584-693-11

Brand name
Doxycycline
Generic name
Doxycycline Hyclate
Active ingredient
Doxycycline Hyclate
Route
Oral
NDC
62584-693
FDA application
ANDA065095
Affected lot / code info
Lot 172569, Exp 7/31/2019

Why it was recalled

Failed Dissolution Specifications: Out of specification result for the dissolution test.

Recalling firm

Firm
American Health Packaging
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2550 John Glenn Ave Ste A, N/A, Columbus, Ohio 43217-1188

Distribution

Quantity
6,579 cartons
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2018-08-01
FDA classified
2019-07-31
Posted by FDA
2019-08-07
Terminated
2020-09-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1582-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Doxycycline · FDA Drug Recalls